Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 7 Associations Among PCP Activation and CVF and PICP
(A) Positive correlation (y = 0.012x + 27.48) between the reduction in PCP activation (as assessed by the ratio of PCP active form to PCP zymogen) and the reduction in myocardial CVF in patients with chronic heart failure treated with torasemide. (B) Positive correlation (y = 0.483x + 9.979) between the reduction in PCP activation (as assessed by the ratio of PCP active form to PCP zymogen) and the reduction in serum PICP in patients with chronic HF treated with torasemide. Abbreviations as in Figure 6.
|
